Harding D R, Hancock W S, Sparrow J T
Int J Pept Protein Res. 1985 Aug;26(2):208-13. doi: 10.1111/j.1399-3011.1985.tb03198.x.
The amino terminal fragment (1-15) of apolipoprotein C-1, H-Thr-Pro-Asp-Val-Ser-Ser-Ala-Leu-Asp-Lys-Leu-Lys-Glu-Phe14-Gly was prepared by the solid phase method. However, the phenylalanine residue at position 14 was replaced with p-iodophenylalanine in the chemical synthesis. The preparation of t-butyloxy-carbonyl-p-iodophenylalanine is described. After completion of the synthesis, the product was deprotected and cleaved from the resin with liquid HF. The peptide was purified by gel filtration on Sephadex G-25 and preparative high performance liquid chromatography. The purified material was shown to be homogeneous by amino acid analytical data and by chromatography in three different analytical reversed phase HPLC systems. The peptide was then labelled by the chloroamine-T procedure and good incorporation of 125I was obtained. After purification of the product by gel filtration on Biogel P-2, the labelled pentadecapeptide was tested for ability to bind to Very Low Density Lipoproteins (VLDL) in the following manner: VLDL was isolated from normolipemic serum by ultracentrifugal flotation and 100-microliter samples were incubated with labelled material dissolved in 200 microliter of 0.5 M NaCl, 0.02 M sodium phosphate buffer, pH 7.4 at 37 degrees for 30 min. The VLDL fraction was again isolated by ultracentrifugal flotation and the incorporation of radioactivity into the lipoprotein was measured. Under these conditions, a sample of [3H]-native apolipoprotein C-I was incorporated to an extent of 83% of the total sample, while the [125I]-pentadecapeptide exhibited an incorporation of 8.7%.
载脂蛋白C-1的氨基末端片段(1-15),即H-Thr-Pro-Asp-Val-Ser-Ser-Ala-Leu-Asp-Lys-Leu-Lys-Glu-Phe14-Gly,通过固相法制备。然而,在化学合成过程中,第14位的苯丙氨酸残基被对碘苯丙氨酸取代。文中描述了叔丁氧羰基-对碘苯丙氨酸的制备方法。合成完成后,产物用液体HF脱保护并从树脂上裂解下来。该肽通过Sephadex G-25凝胶过滤和制备型高效液相色谱进行纯化。氨基酸分析数据以及在三种不同的反相高效液相色谱分析系统中的色谱分析结果表明,纯化后的物质是均一的。然后,该肽通过氯胺-T法进行标记,并获得了良好的125I掺入率。在通过Biogel P-2凝胶过滤对产物进行纯化后,以下列方式测试标记的十五肽与极低密度脂蛋白(VLDL)结合的能力:通过超速离心浮选从正常血脂血清中分离VLDL,将100微升样品与溶解在200微升0.5M NaCl、0.02M磷酸钠缓冲液(pH 7.4)中的标记物质在37℃孵育30分钟。再次通过超速离心浮选分离VLDL部分,并测量脂蛋白中放射性的掺入量。在这些条件下,[3H] - 天然载脂蛋白C-I样品的掺入量占总样品的83%,而[125I] - 十五肽的掺入量为8.7%。